What is acalatinib/acatinib?

Acalabrutinib is an antineoplastic drug indicated for the treatment of adults with mantle cell lymphoma who have received at least one previous treatment for mantle cell lymphoma. Acalabrutinib/Acalabrutinib(Acalabrutinib) is also used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Before taking this medication, tell your doctor if you have or have had any of the following conditions: Active or chronic infection, including hepatitis B;Irregular heartbeat; bleeding problems; recent surgery or planned surgery, medical or dental procedure, or liver disease. Taking acalabrutinib may increase your risk of other cancers, ask your doctor about this risk. Before starting this treatment, patients may need to have a negative pregnancy test. Acalabrutinib may cause birth defects, please do not use if is pregnant. Patients must use effective birth control while taking acalabrutinib and for at least 1 week after the last dose. Do not breastfeed while using acalabrutinib for at least 2 weeks after the last dose. Sometimes it is unsafe to use certain drugs togetherSome drugs can affect the blood levels of other drugs used, which may increase side effects or make the drugs less effective. If patientsare taking stomach acid reducers such as cimetidine, ranitidine, Tagamet, Pepcid, or Zantac, take acafatinib 2 hours before taking any other medicines. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0